ADMA Stock: Price, Earnings History and SEC Filings
ADMA Biologics, Inc. (ADMA) last traded at $11.41, down 2.89% on the latest session and up 13.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.16 against an analyst estimate of $0.16, a beat of 0.0%.
$11.41 -2.89%
1 month+13.76%
52-week high$20.46
52-week low$7.21
Volume2.46M
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ADMA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $0.16 | $0.16 | +0.00% |
| Sep 2025 | Nov 5, 2025 | $0.16 | $0.16 | +0.00% |
ADMA beat the analyst EPS estimate in 0 of its last 2 reported quarters. Source: Nasdaq.
Latest SEC filings for ADMA
SEC filing data is not available right now. You can search for ADMA on SEC EDGAR.
ADMA news
- GeneDx Holdings And 2 Other Top Healthcare StocksOct 31, 2026 · finance.yahoo.com
- Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to NoteOct 30, 2026 · finance.yahoo.com
- Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a BetOct 29, 2026 · finance.yahoo.com
- Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to KnowOct 29, 2026 · finance.yahoo.com
- ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026Oct 28, 2026 · finance.yahoo.com
- Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth KnowingOct 20, 2026 · finance.yahoo.com
About ADMA Biologics, Inc.
ADMA Biologics, Inc. (ADMA) is a US-listed public company on Nasdaq.